Company · CIK 0000203527 · SIC 3845 — Electromedical & Electrotherapeutic Apparatus
VARIAN MEDICAL SYSTEMS INC · VAR
Insider activity reported against this company. All insider holders · Files at: VREX. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2019 SForm 4 → | Mar 12, 9:11 pm EDT | Kolleen T KennedyPres. Proton Solutions, CGO | 1,243 | $132.96 | $165,268 | 26,898 | −4.42% | plan? |
| Mar 8, 2019 MForm 4 → | Mar 12, 9:11 pm EDT | Kolleen T KennedyPres. Proton Solutions, CGO | 1,243 | $94.56 | $117,541 | 27,598 | — | plan? |
| Feb 19, 2019 SForm 4 → | Feb 20, 6:59 pm EST | Kolleen T KennedyPres. Proton Solutions, CGO | 2,225 | $131.60 | $292,810 | 26,898 | −7.64% | plan? |
| Feb 19, 2019 SForm 4 → | Feb 20, 6:51 pm EST | Magnus MomsenSVP, CAO, Corporate Controller | 1,446 | $131.56 | $190,237 | 681 | −68.0% | plan? |
| Feb 15, 2019 FMForm 4 → | Feb 20, 7:14 pm EST | John W KuoSVP, Gen Counsel and Secretary | 3,985 | $132.74 | $133,005 | 36,856 | — | plan? |
| Feb 15, 2019 SForm 4 → | Feb 20, 7:09 pm EST | Gary E Bischoping Jr.SVP, Finance & CFO | 300 | $131.69 | $39,508 | 1,283 | −19.0% | plan? |
| Feb 15, 2019 FMForm 4 → | Feb 20, 7:09 pm EST | Gary E Bischoping Jr.SVP, Finance & CFO | 1,249 | $132.74 | $44,202 | 1,583 | — | plan? |
| Feb 15, 2019 FMForm 4 → | Feb 20, 6:59 pm EST | Kolleen T KennedyPres. Proton Solutions, CGO | 6,313 | $132.74 | $271,321 | 29,123 | — | plan? |
| Feb 15, 2019 FMForm 4 → | Feb 20, 6:51 pm EST | Magnus MomsenSVP, CAO, Corporate Controller | 2,962 | $132.74 | $100,617 | 2,127 | — | plan? |
| Feb 15, 2019 FGMForm 4 → | Feb 20, 6:49 pm EST | Dow R WilsonPresident and CEO, Director | 32,155 | $132.74 | $415,609 | 64,483 | — | plan? |
| Feb 15, 2019 FMForm 4 → | Feb 20, 6:46 pm EST | Christopher A. TothSVP and Pres. Oncology Systems | 4,676 | $132.74 | $161,412 | 2,244 | — | plan? |
| Feb 12, 2019 SForm 4 → | Feb 14, 7:12 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | $132.57 | $144,233 | 26,898 | −3.89% | plan? |
| Feb 12, 2019 MForm 4 → | Feb 14, 7:12 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | $67.12 | $73,027 | 27,567 | — | plan? |
| Feb 11, 2019 MForm 4 → | Feb 14, 9:04 pm EST | Susan L BostromDirector | 3,825 | — | — | 7,634 | — | plan? late |
| Feb 11, 2019 MForm 4 → | Feb 14, 8:49 pm EST | R Andrew EckertDirector | 3,825 | — | — | 13,301 | — | plan? late |
| Feb 11, 2019 MForm 4 → | Feb 14, 8:37 pm EST | David J IllingworthDirector | 3,825 | — | — | 10,911 | — | plan? late |
| Feb 11, 2019 MForm 4 → | Feb 14, 8:35 pm EST | Regina E DuganDirector | 3,825 | — | — | 7,938 | — | plan? late |
| Feb 11, 2019 FMForm 4 → | Feb 14, 8:34 pm EST | Jean Luc ButelDirector | 1,873 | $131.09 | $56,631 | 1,009 | — | plan? late |
| Feb 11, 2019 MForm 4 → | Feb 14, 8:31 pm EST | Judy BrunerDirector | 1,441 | — | — | 1,441 | — | plan? late |
| Feb 11, 2019 SForm 4 → | Feb 13, 7:58 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 699 | $131.45 | $91,886 | 26,898 | −2.53% | plan? |
| Feb 11, 2019 MForm 4 → | Feb 13, 7:58 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 699 | $80.40 | $56,200 | 27,597 | — | plan? |
| Feb 8, 2019 SForm 4 → | Feb 12, 4:41 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 6,517 | $130.10 | $847,849 | 26,898 | −19.5% | plan? |
| Feb 8, 2019 MForm 4 → | Feb 12, 4:41 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 6,517 | $112.82 | $735,248 | 27,327 | — | plan? |
| Jan 28, 2019 SForm 4 → | Jan 30, 8:00 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 19,580 | $130.48 | $2,554,742 | 26,898 | −42.1% | plan? |
| Jan 28, 2019 MForm 4 → | Jan 30, 8:00 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 19,580 | $71.62 | $1,402,325 | 27,830 | — | plan? |
| Jan 28, 2019 SForm 4 → | Jan 30, 7:58 pm EST | R Andrew EckertDirector | 5,651 | $130.15 | $735,478 | 9,476 | −37.4% | plan? |
| Jan 11, 2019 SForm 4 → | Jan 15, 4:51 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 6,462 | $125.00 | $807,750 | 26,898 | −19.4% | plan? |
| Jan 3, 2019 SForm 4 → | Jan 7, 4:02 pm EST | Magnus MomsenSVP, CAO, Corporate Controller | 2,800 | $110.17 | $308,466 | 681 | −80.4% | plan? |
| Jan 3, 2019 MForm 4 → | Jan 7, 4:02 pm EST | Magnus MomsenSVP, CAO, Corporate Controller | 2,800 | $74.06 | $207,368 | 881 | — | plan? |
| Nov 16, 2018 AFGForm 4 → | Nov 20, 2:40 pm EST | Dow R WilsonPresident and CEO, Director | 68,375 | $118.76 | $2,100,983 | 78,590 | — | plan? |
| Nov 16, 2018 AFForm 4 → | Nov 20, 2:39 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 17,482 | $118.76 | $654,368 | 33,360 | — | plan? |
| Nov 16, 2018 AFForm 4 → | Nov 20, 2:37 pm EST | John W KuoSVP, Gen Counsel and Secretary | 14,203 | $118.76 | $559,003 | 34,875 | — | plan? |
| Nov 15, 2018 SForm 4 → | Nov 16, 6:12 pm EST | John W KuoSVP, Gen Counsel and Secretary | 1,324 | $115.50 | $152,923 | 30,086 | −4.22% | plan? |
| Nov 15, 2018 MForm 4 → | Nov 16, 6:12 pm EST | John W KuoSVP, Gen Counsel and Secretary | 1,324 | $71.75 | $95,002 | 30,648 | — | plan? |
| Nov 2, 2018 GMForm 4 → | Feb 14, 2019, 8:32 pm EST | Timothy E GuertinDirector | 20,500 | — | — | 7,938 | — | plan? late |
| Oct 31, 2018 SForm 4 → | Nov 1, 6:52 pm EDT | Gary E Bischoping Jr.SVP, Finance & CFO | 845 | $120.24 | $101,603 | 1,000 | −45.8% | plan? |
| Oct 30, 2018 GMForm 4 → | Jan 30, 2019, 7:58 pm EST | R Andrew EckertDirector | 6,726 | $57.27 | $323,633 | 15,127 | — | plan? late |
| Oct 29, 2018 SForm 4 → | Oct 31, 3:18 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 465 | $111.99 | $52,074 | 30,086 | −1.52% | plan? |
| Oct 29, 2018 MForm 4 → | Oct 31, 3:18 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 465 | $80.40 | $37,386 | 30,551 | — | plan? |
| Oct 29, 2018 SForm 4 → | Oct 31, 3:16 pm EDT | Magnus MomsenSVP, CAO, Corporate Controller | 2,700 | $111.72 | $301,639 | 681 | −79.9% | plan? |
| Oct 29, 2018 MForm 4 → | Oct 31, 3:16 pm EDT | Magnus MomsenSVP, CAO, Corporate Controller | 2,700 | $68.42 | $184,747 | 2,224 | — | plan? |
| Oct 15, 2018 SForm 4 → | Oct 17, 2:22 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 862 | $105.26 | $90,737 | 30,086 | −2.79% | plan? |
| Oct 15, 2018 MForm 4 → | Oct 17, 2:22 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 862 | $67.12 | $57,857 | 30,348 | — | plan? |
| Oct 4, 2018 SForm 4 → | Oct 5, 5:55 pm EDT | Magnus MomsenSVP, CAO, Corporate Controller | 100 | $110.21 | $11,021 | 624 | −13.8% | plan? |
| Oct 4, 2018 MForm 4 → | Oct 5, 5:55 pm EDT | Magnus MomsenSVP, CAO, Corporate Controller | 100 | $60.91 | $6,091 | 724 | — | plan? |
| Sep 17, 2018 SForm 4 → | Sep 19, 6:43 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,327 | $110.90 | $147,167 | 30,086 | −4.22% | plan? |
| Sep 17, 2018 MForm 4 → | Sep 19, 6:43 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,327 | $71.77 | $95,243 | 30,948 | — | plan? |
| Sep 5, 2018 SForm 4 → | Sep 6, 2:09 pm EDT | Timothy E GuertinDirector | 10,000 | $110.84 | $1,108,362 | 55,800 | −15.2% | plan? |
| Sep 4, 2018 SForm 4 → | Sep 6, 2:02 pm EDT | Magnus MomsenSVP, CAO, Corporate Controller | 2,800 | $111.68 | $312,696 | 624 | −81.8% | plan? |
| Sep 4, 2018 MForm 4 → | Sep 6, 2:02 pm EDT | Magnus MomsenSVP, CAO, Corporate Controller | 2,800 | $60.91 | $170,548 | 3,424 | — | plan? |
| Aug 16, 2018 SForm 4 → | Aug 20, 12:56 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 365 | $110.00 | $40,150 | 30,086 | −1.20% | plan? |
| Aug 16, 2018 MForm 4 → | Aug 20, 12:56 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 365 | $80.40 | $29,346 | 30,451 | — | plan? |
| Aug 15, 2018 SForm 4 → | Aug 17, 12:18 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 962 | $108.84 | $104,707 | 30,086 | −3.10% | plan? |
| Aug 15, 2018 MForm 4 → | Aug 17, 12:18 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 962 | $68.50 | $65,897 | 30,186 | — | plan? |
| Jul 16, 2018 SForm 4 → | Jul 18, 11:40 am EDT | John W KuoSVP, Gen Counsel and Secretary | 1,327 | $115.28 | $152,974 | 30,086 | −4.22% | plan? |
| Jul 16, 2018 MForm 4 → | Jul 18, 11:40 am EDT | John W KuoSVP, Gen Counsel and Secretary | 1,327 | $71.77 | $95,243 | 30,551 | — | plan? |
| Jun 15, 2018 SForm 4 → | Jun 18, 5:57 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,329 | $122.55 | $162,871 | 30,086 | −4.23% | plan? |
| Jun 15, 2018 MForm 4 → | Jun 18, 5:57 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,329 | $71.77 | $95,378 | 30,551 | — | plan? |
| May 18, 2018 FMForm 4 → | May 21, 1:49 pm EDT | Gary E Bischoping Jr.SVP, Finance & CFO | 3,793 | $118.40 | $115,322 | 1,845 | — | plan? |
| May 15, 2018 SForm 4 → | May 16, 1:30 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,327 | $117.15 | $155,460 | 30,086 | −4.22% | plan? |
| May 15, 2018 MForm 4 → | May 16, 1:30 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,327 | $71.77 | $95,243 | 30,948 | — | plan? |
| May 10, 2018 SForm 4 → | May 11, 5:23 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 699 | $118.20 | $82,624 | 26,856 | −2.54% | plan? |
| May 10, 2018 MForm 4 → | May 11, 5:23 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 699 | $80.40 | $56,200 | 27,555 | — | plan? |
| Apr 16, 2018 SForm 4 → | Apr 17, 5:40 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,328 | $121.94 | $161,935 | 29,845 | −4.26% | plan? |
| Apr 16, 2018 MForm 4 → | Apr 17, 5:40 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,328 | $71.77 | $95,311 | 31,173 | — | plan? |
| Apr 10, 2018 SForm 4 → | Apr 10, 6:54 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 699 | $120.33 | $84,113 | 26,662 | −2.55% | plan? |
| Apr 10, 2018 MForm 4 → | Apr 10, 6:54 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 699 | $80.40 | $56,200 | 27,361 | — | plan? |
| Mar 15, 2018 SForm 4 → | Mar 15, 8:47 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,328 | $125.51 | $166,672 | 29,845 | −4.26% | plan? |
| Mar 15, 2018 MForm 4 → | Mar 15, 8:47 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,328 | $71.77 | $95,311 | 31,173 | — | plan? |
| Mar 12, 2018 SForm 4 → | Mar 12, 8:00 pm EDT | Magnus MomsenSVP, CAO, Corporate Controller | 1,556 | $126.47 | $196,792 | 6,588 | −19.1% | plan? |
| Mar 12, 2018 SForm 4 → | Mar 12, 7:56 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 699 | $126.47 | $88,401 | 26,662 | −2.55% | plan? |
| Mar 12, 2018 MForm 4 → | Mar 12, 7:56 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 699 | $80.40 | $56,200 | 27,361 | — | plan? |
| Mar 6, 2018 SForm 4 → | Mar 7, 6:59 pm EST | David J IllingworthDirector | 5,651 | $122.56 | $692,560 | 7,086 | −44.4% | plan? |
| Mar 6, 2018 MForm 4 → | Mar 7, 6:59 pm EST | David J IllingworthDirector | 5,651 | $57.27 | $323,633 | 12,737 | — | plan? |
| Mar 1, 2018 SForm 4 → | Mar 2, 6:08 pm EST | Dow R WilsonPresident and CEO, Director | 24,000 | $118.03 | $2,832,802 | 75,356 | −24.2% | plan? |
| Mar 1, 2018 MForm 4 → | Mar 2, 6:08 pm EST | Dow R WilsonPresident and CEO, Director | 24,000 | $74.06 | $1,777,440 | 99,356 | — | plan? |
| Feb 22, 2018 SForm 4 → | Feb 22, 7:22 pm EST | Susan L BostromDirector | 1,952 | $120.60 | $235,413 | 3,809 | −33.9% | plan? |
| Feb 16, 2018 SForm 4 → | Feb 16, 7:10 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 3,513 | $121.16 | $425,622 | 26,662 | −11.6% | plan? |
| Feb 15, 2018 FMForm 4 → | Feb 16, 7:17 pm EST | Magnus MomsenSVP, CAO, Corporate Controller | 3,304 | $121.87 | $106,514 | 8,144 | — | plan? |
| Feb 15, 2018 SForm 4 → | Feb 16, 7:14 pm EST | John W KuoSVP, Gen Counsel and Secretary | 6,442 | $120.67 | $777,343 | 27,361 | −19.1% | plan? |
| Feb 15, 2018 FMForm 4 → | Feb 16, 7:14 pm EST | John W KuoSVP, Gen Counsel and Secretary | 11,852 | $86.63 | $684,772 | 29,845 | — | plan? |
| Feb 15, 2018 FMForm 4 → | Feb 16, 7:10 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 7,015 | $121.87 | $213,394 | 30,175 | — | plan? |
| Feb 15, 2018 FMForm 4 → | Feb 16, 7:01 pm EST | Dow R WilsonPresident and CEO, Director | 24,378 | $121.87 | $962,651 | 75,356 | — | plan? |
| Feb 13, 2018 MForm 4 → | Feb 14, 9:12 pm EST | Regina E DuganDirector | 1,952 | — | — | 4,113 | — | plan? |
| Feb 13, 2018 MForm 4 → | Feb 14, 9:09 pm EST | Timothy E GuertinDirector | 1,952 | — | — | 4,113 | — | plan? |
| Feb 13, 2018 MForm 4 → | Feb 14, 9:06 pm EST | David J IllingworthDirector | 1,952 | — | — | 7,086 | — | plan? |
| Feb 13, 2018 MForm 4 → | Feb 14, 9:03 pm EST | R Andrew EckertDirector | 1,952 | — | — | 10,551 | — | plan? |
| Feb 13, 2018 MForm 4 → | Feb 14, 9:00 pm EST | Susan L BostromDirector | 1,952 | — | — | 5,761 | — | plan? |
| Feb 12, 2018 SForm 4 → | Feb 13, 6:47 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 8,390 | $116.47 | $977,164 | 26,662 | −23.9% | plan? |
| Feb 12, 2018 MForm 4 → | Feb 13, 6:47 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 8,390 | $80.40 | $674,556 | 35,052 | — | plan? |
| Feb 8, 2018 GForm 4 → | Feb 12, 7:52 pm EST | R Andrew EckertDirector | 400 | — | — | 8,599 | — | plan? |
| Feb 8, 2018 MForm 4 → | Feb 8, 8:27 pm EST | Mark R LaretDirector | 6,326 | — | — | 6,326 | — | plan? |
| Feb 1, 2018 SForm 4 → | Feb 2, 7:13 pm EST | Dow R WilsonPresident and CEO, Director | 24,000 | $126.73 | $3,041,469 | 66,776 | −26.4% | plan? |
| Feb 1, 2018 MForm 4 → | Feb 2, 7:13 pm EST | Dow R WilsonPresident and CEO, Director | 24,000 | $74.06 | $1,777,440 | 90,776 | — | plan? |
| Feb 1, 2018 SForm 4 → | Feb 2, 7:09 pm EST | Mark R LaretDirector | 2,161 | $126.97 | $274,383 | 0 | −100% | plan? |
| Jan 16, 2018 SForm 4 → | Jan 17, 7:05 pm EST | John W KuoSVP, Gen Counsel and Secretary | 863 | $108.43 | $93,575 | 27,361 | −3.06% | plan? |
| Jan 16, 2018 MForm 4 → | Jan 17, 7:05 pm EST | John W KuoSVP, Gen Counsel and Secretary | 863 | $67.12 | $57,925 | 28,224 | — | plan? |
| Jan 16, 2018 SForm 4 → | Jan 17, 6:58 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 933 | $108.31 | $101,056 | 26,662 | −3.38% | plan? |
| Jan 16, 2018 MForm 4 → | Jan 17, 6:58 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 933 | $81.97 | $76,478 | 27,595 | — | plan? |
| Jan 12, 2018 SForm 4 → | Jan 16, 5:04 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,089 | $108.19 | $117,823 | 26,662 | −3.92% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2019 MForm 4 → | Mar 12, 9:11 pm EDT | Kolleen T KennedyPres. Proton Solutions, CGO | 1,243 | — | — | 7,691 | — | |
| Feb 15, 2019 MForm 4 → | Feb 20, 7:14 pm EST | John W KuoSVP, Gen Counsel and Secretary | 2,983 | — | — | 4,765 | — | |
| Feb 15, 2019 MForm 4 → | Feb 20, 7:09 pm EST | Gary E Bischoping Jr.SVP, Finance & CFO | 916 | — | — | 9,823 | — | |
| Feb 15, 2019 MForm 4 → | Feb 20, 6:59 pm EST | Kolleen T KennedyPres. Proton Solutions, CGO | 4,269 | — | — | 7,353 | — | |
| Feb 15, 2019 MForm 4 → | Feb 20, 6:51 pm EST | Magnus MomsenSVP, CAO, Corporate Controller | 2,204 | — | — | 2,604 | — | |
| Feb 15, 2019 MForm 4 → | Feb 20, 6:49 pm EST | Dow R WilsonPresident and CEO, Director | 9,024 | — | — | 5,017 | — | |
| Feb 15, 2019 MForm 4 → | Feb 20, 6:46 pm EST | Christopher A. TothSVP and Pres. Oncology Systems | 3,460 | — | — | 93 | — | |
| Feb 15, 2019 AForm 4 → | Feb 20, 6:44 pm EST | Jean Luc ButelDirector | 1,243 | — | — | 1,243 | — | |
| Feb 15, 2019 AForm 4 → | Feb 20, 6:42 pm EST | Regina E DuganDirector | 1,243 | — | — | 1,243 | — | |
| Feb 15, 2019 AForm 4 → | Feb 20, 6:40 pm EST | Timothy E GuertinDirector | 1,243 | — | — | 1,243 | — | |
| Feb 15, 2019 AForm 4 → | Feb 20, 6:38 pm EST | David J IllingworthDirector | 1,243 | — | — | 1,243 | — | |
| Feb 15, 2019 AForm 4 → | Feb 20, 6:36 pm EST | Anat AshkenaziDirector | 1,349 | — | — | 1,349 | — | |
| Feb 15, 2019 AForm 4 → | Feb 20, 6:34 pm EST | Jeffrey R. BalserDirector | 1,243 | — | — | 1,599 | — | |
| Feb 15, 2019 AForm 4 → | Feb 20, 6:33 pm EST | R Andrew EckertDirector | 1,243 | — | — | 1,243 | — | |
| Feb 15, 2019 AForm 4 → | Feb 20, 6:31 pm EST | Judy BrunerDirector | 1,243 | — | — | 1,243 | — | |
| Feb 14, 2019 AForm 4 → | Feb 19, 8:09 pm EST | Gary E Bischoping Jr.SVP, Finance & CFO | 12,984 | — | — | 10,739 | — | |
| Feb 14, 2019 AForm 4 → | Feb 19, 7:40 pm EST | Christopher A. TothSVP and Pres. Oncology Systems | 10,470 | — | — | 3,553 | — | |
| Feb 14, 2019 AForm 4 → | Feb 19, 7:35 pm EST | Magnus MomsenSVP, CAO, Corporate Controller | 4,188 | — | — | 4,808 | — | |
| Feb 14, 2019 AForm 4 → | Feb 19, 7:31 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 17,590 | — | — | 11,622 | — | |
| Feb 14, 2019 AForm 4 → | Feb 19, 7:18 pm EST | John W KuoSVP, Gen Counsel and Secretary | 11,308 | — | — | 7,748 | — | |
| Feb 12, 2019 MForm 4 → | Feb 14, 7:12 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | — | — | 0 | — | |
| Feb 11, 2019 MForm 4 → | Feb 14, 9:04 pm EST | Susan L BostromDirector | 3,825 | — | — | 1,990 | — | late |
| Feb 11, 2019 MForm 4 → | Feb 14, 8:49 pm EST | R Andrew EckertDirector | 3,825 | — | — | 1,990 | — | late |
| Feb 11, 2019 MForm 4 → | Feb 14, 8:37 pm EST | David J IllingworthDirector | 3,825 | — | — | 1,990 | — | late |
| Feb 11, 2019 MForm 4 → | Feb 14, 8:35 pm EST | Regina E DuganDirector | 3,825 | — | — | 1,990 | — | late |
| Feb 11, 2019 MForm 4 → | Feb 14, 8:34 pm EST | Jean Luc ButelDirector | 1,441 | — | — | 0 | — | late |
| Feb 11, 2019 MForm 4 → | Feb 14, 8:32 pm EST | Timothy E GuertinDirector | 3,825 | — | — | 1,990 | — | late |
| Feb 11, 2019 MForm 4 → | Feb 14, 8:31 pm EST | Judy BrunerDirector | 1,441 | — | — | 0 | — | late |
| Feb 11, 2019 MForm 4 → | Feb 13, 7:58 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 699 | — | — | 8,391 | — | |
| Feb 8, 2019 MForm 4 → | Feb 12, 4:41 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 6,517 | — | — | 13,036 | — | |
| Jan 28, 2019 MForm 4 → | Jan 30, 8:00 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 19,580 | — | — | 0 | — | |
| Jan 28, 2019 MForm 4 → | Jan 30, 7:58 pm EST | R Andrew EckertDirector | 5,651 | — | — | 0 | — | |
| Jan 3, 2019 MForm 4 → | Jan 7, 4:02 pm EST | Magnus MomsenSVP, CAO, Corporate Controller | 2,800 | — | — | 0 | — | |
| Nov 15, 2018 AForm 4 → | Dec 4, 3:08 pm EST | Jeffrey R. BalserDirector | 356 | — | — | 356 | — | late |
| Nov 15, 2018 MForm 4 → | Nov 16, 6:12 pm EST | John W KuoSVP, Gen Counsel and Secretary | 1,324 | — | — | 2,592 | — | |
| Oct 29, 2018 MForm 4 → | Oct 31, 3:18 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 465 | — | — | 7,440 | — | |
| Oct 29, 2018 MForm 4 → | Oct 31, 3:16 pm EDT | Magnus MomsenSVP, CAO, Corporate Controller | 2,700 | — | — | 2,800 | — | |
| Oct 15, 2018 MForm 4 → | Oct 17, 2:22 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 862 | — | — | 3,454 | — | |
| Oct 4, 2018 MForm 4 → | Oct 5, 5:55 pm EDT | Magnus MomsenSVP, CAO, Corporate Controller | 100 | — | — | 1,157 | — | |
| Sep 17, 2018 MForm 4 → | Sep 19, 6:43 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,327 | — | — | 4,316 | — | |
| Sep 4, 2018 MForm 4 → | Sep 6, 2:02 pm EDT | Magnus MomsenSVP, CAO, Corporate Controller | 2,800 | — | — | 1,257 | — | |
| Aug 16, 2018 MForm 4 → | Aug 20, 12:56 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 365 | — | — | 8,370 | — | |
| Aug 15, 2018 MForm 4 → | Aug 17, 12:18 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 962 | — | — | 8,735 | — | |
| Jul 16, 2018 MForm 4 → | Jul 18, 11:40 am EDT | John W KuoSVP, Gen Counsel and Secretary | 1,327 | — | — | 8,835 | — | |
| Jun 15, 2018 MForm 4 → | Jun 18, 5:57 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,329 | — | — | 9,300 | — | |
| May 18, 2018 MForm 4 → | May 21, 1:49 pm EDT | Gary E Bischoping Jr.SVP, Finance & CFO | 2,819 | — | — | 8,386 | — | |
| May 15, 2018 MForm 4 → | May 16, 1:30 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,327 | — | — | 7,766 | — | |
| May 10, 2018 MForm 4 → | May 11, 5:23 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 699 | — | — | 14,683 | — | |
| Apr 16, 2018 MForm 4 → | Apr 17, 5:40 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,328 | — | — | 10,230 | — | |
| Apr 10, 2018 MForm 4 → | Apr 10, 6:54 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 699 | — | — | 15,382 | — | |
| Mar 15, 2018 MForm 4 → | Mar 15, 8:47 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,328 | — | — | 10,695 | — | |
| Mar 12, 2018 MForm 4 → | Mar 12, 7:56 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 699 | — | — | 16,081 | — | |
| Mar 6, 2018 MForm 4 → | Mar 7, 6:59 pm EST | David J IllingworthDirector | 5,651 | — | — | 0 | — | |
| Mar 1, 2018 MForm 4 → | Mar 2, 6:08 pm EST | Dow R WilsonPresident and CEO, Director | 24,000 | — | — | 45,050 | — | |
| Feb 15, 2018 MForm 4 → | Feb 16, 7:17 pm EST | Magnus MomsenSVP, CAO, Corporate Controller | 2,430 | — | — | 4,049 | — | |
| Feb 15, 2018 MForm 4 → | Feb 16, 7:14 pm EST | John W KuoSVP, Gen Counsel and Secretary | 10,389 | — | — | 5,699 | — | |
| Feb 15, 2018 MForm 4 → | Feb 16, 7:10 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 5,264 | — | — | 8,435 | — | |
| Feb 15, 2018 MForm 4 → | Feb 16, 7:01 pm EST | Dow R WilsonPresident and CEO, Director | 16,479 | — | — | 14,041 | — | |
| Feb 13, 2018 MForm 4 → | Feb 14, 9:12 pm EST | Regina E DuganDirector | 1,952 | — | — | 4,374 | — | |
| Feb 13, 2018 MForm 4 → | Feb 14, 9:09 pm EST | Timothy E GuertinDirector | 1,952 | — | — | 4,374 | — | |
| Feb 13, 2018 MForm 4 → | Feb 14, 9:06 pm EST | David J IllingworthDirector | 1,952 | — | — | 4,374 | — | |
| Feb 13, 2018 MForm 4 → | Feb 14, 9:03 pm EST | R Andrew EckertDirector | 1,952 | — | — | 4,374 | — | |
| Feb 13, 2018 MForm 4 → | Feb 14, 9:00 pm EST | Susan L BostromDirector | 1,952 | — | — | 4,374 | — | |
| Feb 12, 2018 MForm 4 → | Feb 13, 6:47 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 8,390 | — | — | 16,780 | — | |
| Feb 9, 2018 AForm 4 → | Feb 12, 8:19 pm EST | Jean Luc ButelDirector | 1,441 | — | — | 1,441 | — | |
| Feb 9, 2018 AForm 4 → | Feb 12, 8:15 pm EST | Jose BaselgaDirector | 1,441 | — | — | 1,441 | — | |
| Feb 9, 2018 AForm 4 → | Feb 12, 8:13 pm EST | Regina E DuganDirector | 1,441 | — | — | 1,441 | — | |
| Feb 9, 2018 AForm 4 → | Feb 12, 8:09 pm EST | Timothy E GuertinDirector | 1,441 | — | — | 1,441 | — | |
| Feb 9, 2018 AForm 4 → | Feb 12, 8:06 pm EST | David J IllingworthDirector | 1,441 | — | — | 1,441 | — | |
| Feb 9, 2018 AForm 4 → | Feb 12, 8:01 pm EST | Susan L BostromDirector | 1,441 | — | — | 1,441 | — | |
| Feb 9, 2018 AForm 4 → | Feb 12, 7:52 pm EST | R Andrew EckertDirector | 1,441 | — | — | 1,441 | — | |
| Feb 9, 2018 AForm 4 → | Feb 12, 7:44 pm EST | Judy BrunerDirector | 1,441 | — | — | 1,441 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 4:02 pm EST | Magnus MomsenSVP, CAO, Corporate Controller | 6,927 | — | — | 6,479 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 3:56 pm EST | Gary E Bischoping Jr.SVP, Finance & CFO | 17,180 | — | — | 11,205 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 3:53 pm EST | John W KuoSVP, Gen Counsel and Secretary | 14,963 | — | — | 9,646 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 3:50 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 23,276 | — | — | 13,699 | — | |
| Feb 8, 2018 MForm 4 → | Feb 8, 8:27 pm EST | Mark R LaretDirector | 6,326 | — | — | 0 | — | |
| Feb 1, 2018 MForm 4 → | Feb 2, 7:13 pm EST | Dow R WilsonPresident and CEO, Director | 24,000 | — | — | 69,050 | — | |
| Jan 16, 2018 MForm 4 → | Jan 17, 7:05 pm EST | John W KuoSVP, Gen Counsel and Secretary | 863 | — | — | 11,217 | — | |
| Jan 16, 2018 MForm 4 → | Jan 17, 6:58 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 933 | — | — | 932 | — | |
| Jan 12, 2018 MForm 4 → | Jan 16, 5:04 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,089 | — | — | 14,143 | — | |
| Jan 8, 2018 MForm 4 → | Jan 10, 3:05 pm EST | John W KuoSVP, Gen Counsel and Secretary | 7,991 | — | — | 1,470 | — | |
| Dec 18, 2017 MForm 4 → | Dec 18, 9:24 pm EST | Dow R WilsonPresident and CEO, Director | 88,766 | — | — | 0 | — | |
| Dec 12, 2017 MForm 4 → | Dec 13, 8:41 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 2,018 | — | — | 1,865 | — | |
| Nov 13, 2017 MForm 4 → | Nov 14, 6:08 pm EST | Kolleen T KennedyEVP and Pres. Oncology Sys. | 2,021 | — | — | 16,319 | — | |
| Oct 18, 2017 MForm 4 → | Oct 19, 8:26 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 931 | — | — | 3,729 | — | |
| Oct 12, 2017 MForm 4 → | Oct 13, 3:23 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | — | — | 17,407 | — | |
| Oct 6, 2017 MForm 4 → | Oct 6, 7:55 pm EDT | R Andrew EckertDirector | 5,651 | — | — | 0 | — | |
| Oct 6, 2017 MForm 4 → | Oct 6, 7:46 pm EDT | Dow R WilsonPresident and CEO, Director | 15,059 | — | — | 0 | — | |
| Sep 13, 2017 MForm 4/A → | Sep 19, 8:40 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 933 | — | — | 4,660 | — | |
| Sep 13, 2017 MForm 4 → | Sep 14, 11:36 am EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 933 | — | — | 4,660 | — | amended |
| Sep 12, 2017 MForm 4/A → | Sep 19, 8:36 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | — | — | 18,495 | — | |
| Sep 12, 2017 MForm 4 → | Sep 13, 11:25 am EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | — | — | 18,495 | — | amended |
| Sep 7, 2017 MForm 4/A → | Sep 19, 8:26 pm EDT | Dow R WilsonPresident and CEO, Director | 15,059 | — | — | 15,059 | — | |
| Sep 7, 2017 MForm 4 → | Sep 8, 3:05 pm EDT | Dow R WilsonPresident and CEO, Director | 15,059 | — | — | 15,059 | — | amended |
| Aug 31, 2017 MForm 4 → | Sep 1, 3:48 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 931 | — | — | 5,593 | — | |
| Aug 14, 2017 MForm 4 → | Aug 15, 7:56 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 1,088 | — | — | 19,583 | — | |
| Aug 7, 2017 MForm 4 → | Aug 8, 8:08 pm EDT | Dow R WilsonPresident and CEO, Director | 15,059 | — | — | 30,118 | — | |
| Jul 12, 2017 MForm 4 → | Jul 13, 8:08 pm EDT | John W KuoSVP, Gen Counsel and Secretary | 1,597 | — | — | 5,145 | — | |
| Jul 12, 2017 MForm 4 → | Jul 13, 7:59 pm EDT | Kolleen T KennedyEVP and Pres. Oncology Sys. | 2,021 | — | — | 6,524 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2017 JForm 4 → | Jan 31, 9:12 pm EST | Varex Imaging CorpVREX | 37,386,730 | — | — | 0 | — | plan? |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.